Idiopathic Pulmonary Fibrosis — New Insights
- 29 March 2007
- journal article
- editorial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 356 (13) , 1370-1372
- https://doi.org/10.1056/nejmcibr070490
Abstract
The signaling molecule caveolin-1 provides protection against pulmonary fibrosis in a mouse model and counters the profibrotic effects of transforming growth factor β1 (TGF-β1)..Keywords
This publication has 7 references indexed in Scilit:
- Telomerase Mutations in Families with Idiopathic Pulmonary FibrosisNew England Journal of Medicine, 2007
- Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosisThe Journal of Experimental Medicine, 2006
- Transforming Growth Factor β Suppresses Human Telomerase Reverse Transcriptase (hTERT) by Smad3 Interactions with c-Myc and the hTERT GeneJournal of Biological Chemistry, 2006
- Caveolae and caveolin in transmembrane signaling: Implications for human diseaseCardiovascular Research, 2006
- Idiopathic pulmonary fibrosis: current understanding of the pathogenesis and the status of treatmentCMAJ : Canadian Medical Association Journal, 2004
- Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorderRespiratory Research, 2001
- Idiopathic interstitial pneumonitis/fibrosis: a historical noteCurrent Opinion in Pulmonary Medicine, 1999